Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.
2.

A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type.

Moene FC, Spinhoven P, Hoogduin KA, van Dyck R.

Int J Clin Exp Hypn. 2003 Jan;51(1):29-50.

PMID:
12825917
3.

The creative use of unexpected responses in the hypnotherapy of patients with conversion disorders.

Moene FC, Hoogduin KA.

Int J Clin Exp Hypn. 1999 Jul;47(3):209-26. Review.

PMID:
10616255
4.

Behavioral management of conversion disorder: retrospective study.

Speed J.

Arch Phys Med Rehabil. 1996 Feb;77(2):147-54.

PMID:
8607738
5.

Hypnotic susceptibility in patients with conversion disorder.

Roelofs K, Hoogduin KA, Keijsers GP, Näring GW, Moene FC, Sandijck P.

J Abnorm Psychol. 2002 May;111(2):390-5.

PMID:
12003460
6.

The inpatient treatment of patients suffering from (motor) conversion symptoms: a description of eight cases.

Moene FC, Hoogduin KA, Van Dyck R.

Int J Clin Exp Hypn. 1998 Apr;46(2):171-90. Review.

PMID:
9558806
7.

Treating adolescent conversion disorders: are hypnotic techniques reusable?

Bloom PB.

Int J Clin Exp Hypn. 2001 Jul;49(3):243-56.

PMID:
11430158
8.

[Case report: electroconvulsive therapy in a 33-year-old man with hysterical quadriplegia].

Gaillard A, Gaillard R, Mouaffak F, Radtchenko A, Lôo H.

Encephale. 2012 Feb;38(1):104-9. doi: 10.1016/j.encep.2011.06.005. French.

PMID:
22381730
9.
10.

Inpatient treatment of conversion disorder: a clinical investigation of outcome.

Krull F, Schifferdecker M.

Psychother Psychosom. 1990;53(1-4):161-5.

PMID:
2290893
11.

Childhood experiences and personality traits in patients with motor conversion symptoms.

Binzer M, Eisemann M.

Acta Psychiatr Scand. 1998 Oct;98(4):288-95.

PMID:
9821450
12.

Hypnosis and conversion disorders.

Van Dyck R, Hoogduin K.

Am J Psychother. 1989 Oct;43(4):480-93. Review.

PMID:
2694843
13.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

14.

Antidepressant treatment outcomes of psychogenic movement disorder.

Voon V, Lang AE.

J Clin Psychiatry. 2005 Dec;66(12):1529-34.

PMID:
16401153
15.

Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.

J Clin Psychiatry. 2001 Aug;62(8):623-30.

PMID:
11561935
17.

[Phenomenology and psychiatric origins of psychogenic non-epileptic seizures].

Ristić AJ, Petrović I, Vojvodić N, Janković S, Sokić D.

Srp Arh Celok Lek. 2004 Jan-Feb;132(1-2):22-7. Serbian.

18.

[The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomised controlled trial].

Schadé A, Marquenie LA, van Balkom AJ, Koeter MM, van den Brink W, van Dyck R.

Tijdschr Psychiatr. 2008;50(3):137-48. Dutch.

20.

The question of symptom lateralization in conversion disorder.

Roelofs K, Näring GW, Moene FC, Hoogduin CA.

J Psychosom Res. 2000 Jul;49(1):21-5.

PMID:
11053600

Supplemental Content

Support Center